 |
PDBsum entry 1e3b
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.2.1.8
- peptidylprolyl isomerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[protein]-peptidylproline (omega=180) = [protein]-peptidylproline (omega=0)
|
 |
 |
 |
 |
 |
Peptidylproline (omega=180)
|
=
|
peptidylproline (omega=0)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Angew Chem Int Ed Engl
39:2931-2934
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
First Crystal Structure of a Medicinally Relevant Gold Protein Complex: Unexpected Binding of
|
|
J.Zou,
P.Taylor,
J.Dornan,
S.P.Robinson,
M.D.Walkinshaw,
P.J.Sadler.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.P.Bhabak,
B.J.Bhuyan,
and
G.Mugesh
(2011).
Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes.
|
| |
Dalton Trans,
40,
2099-2111.
|
 |
|
|
|
|
 |
L.Messori,
A.Balerna,
I.Ascone,
C.Castellano,
C.Gabbiani,
A.Casini,
C.Marchioni,
G.Jaouen,
and
A.Congiu Castellano
(2011).
X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins.
|
| |
J Biol Inorg Chem,
16,
491-499.
|
 |
|
|
|
|
 |
D.S.Hage,
A.Jackson,
M.R.Sobansky,
J.E.Schiel,
M.J.Yoo,
and
K.S.Joseph
(2009).
Characterization of drug-protein interactions in blood using high-performance affinity chromatography.
|
| |
J Sep Sci,
32,
835-853.
|
 |
|
|
|
|
 |
E.Meggers
(2009).
Targeting proteins with metal complexes.
|
| |
Chem Commun (Camb),
(),
1001-1010.
|
 |
|
|
|
|
 |
M.L.Conrad,
A.C.Moser,
and
D.S.Hage
(2009).
Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography.
|
| |
J Sep Sci,
32,
1145-1155.
|
 |
|
|
|
|
 |
X.Liang,
D.J.Campopiano,
and
P.J.Sadler
(2007).
Metals in membranes.
|
| |
Chem Soc Rev,
36,
968-992.
|
 |
|
|
|
|
 |
A.Casini,
C.Gabbiani,
G.Mastrobuoni,
L.Messori,
G.Moneti,
and
G.Pieraccini
(2006).
Exploring metallodrug-protein interactions by ESI mass spectrometry: the reaction of anticancer platinum drugs with horse heart cytochrome c.
|
| |
ChemMedChem,
1,
413-417.
|
 |
|
|
|
|
 |
J.Talib,
J.L.Beck,
and
S.F.Ralph
(2006).
A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin.
|
| |
J Biol Inorg Chem,
11,
559-570.
|
 |
|
|
|
|
 |
S.Urig,
and
K.Becker
(2006).
On the potential of thioredoxin reductase inhibitors for cancer therapy.
|
| |
Semin Cancer Biol,
16,
452-465.
|
 |
|
|
|
|
 |
S.Urig,
K.Fritz-Wolf,
R.Réau,
C.Herold-Mende,
K.Tóth,
E.Davioud-Charvet,
and
K.Becker
(2006).
Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
|
| |
Angew Chem Int Ed Engl,
45,
1881-1886.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Deponte,
S.Urig,
L.D.Arscott,
K.Fritz-Wolf,
R.Réau,
C.Herold-Mende,
S.Koncarevic,
M.Meyer,
E.Davioud-Charvet,
D.P.Ballou,
C.H.Williams,
and
K.Becker
(2005).
Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase.
|
| |
J Biol Chem,
280,
20628-20637.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |